Correlation Between Eupraxia Pharmaceuticals and VSee Health,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and VSee Health, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and VSee Health, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and VSee Health,, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and VSee Health, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of VSee Health,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and VSee Health,.

Diversification Opportunities for Eupraxia Pharmaceuticals and VSee Health,

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Eupraxia and VSee is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and VSee Health, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VSee Health, and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with VSee Health,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VSee Health, has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and VSee Health, go up and down completely randomly.

Pair Corralation between Eupraxia Pharmaceuticals and VSee Health,

Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to generate 0.98 times more return on investment than VSee Health,. However, Eupraxia Pharmaceuticals Common is 1.02 times less risky than VSee Health,. It trades about 0.1 of its potential returns per unit of risk. VSee Health, is currently generating about -0.06 per unit of risk. If you would invest  255.00  in Eupraxia Pharmaceuticals Common on September 26, 2024 and sell it today you would earn a total of  51.00  from holding Eupraxia Pharmaceuticals Common or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eupraxia Pharmaceuticals Commo  vs.  VSee Health,

 Performance 
       Timeline  
Eupraxia Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
VSee Health, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in VSee Health, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, VSee Health, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Eupraxia Pharmaceuticals and VSee Health, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eupraxia Pharmaceuticals and VSee Health,

The main advantage of trading using opposite Eupraxia Pharmaceuticals and VSee Health, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, VSee Health, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VSee Health, will offset losses from the drop in VSee Health,'s long position.
The idea behind Eupraxia Pharmaceuticals Common and VSee Health, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum